Delivery Order SPE2DB20D3103-SPE2DB23FP2Y3
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $8,444.49, for the supply of DEXRAZOXANE 500 MG VIALS. The contract has an ultimate completion date of March 13, 2025 and was awarded on March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,142,760 units of the medication dexrazoxane 500 mg vials, with a ceiling value of $3,424.44. The contract is a firm fixed-price delivery order with a period of performance through May 6, 2025. This contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a...
- The U.S. Department of Defense (DoD) has awarded a Delivery Order contract valued at $2,315.09 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of pharmaceutical products and medical supplies. This includes specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. Amerisourcebergen Drug Corp holds a significant...
- This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the provision of a variety of medical products and supplies. The DO has a ceiling value of $2,581.44 and a period of performance through April 23, 2024. Amerisourcebergen is a subsidiary of Cencora, Inc. and is a major supplier of prescription medications, over-the-counter drugs, and medical supplies to the Department of...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $6,022.37 and is a firm fixed-price delivery order with a completion date of February 23, 2024. The contract is for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $11,132.24. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that supports military healthcare programs. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. Amerisourcebergen holds a...
- This federal contract award is for pharmaceutical and medical supply delivery orders issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has a ceiling value of $5,568.31 and an ultimate completion date of February 22, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The specific DO awarded has a ceiling value of $3,905.77 and a period...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, is for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $39,640.32 and a period of performance through June 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP2Y3Delivery Order
This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of Dexrazoxane 500 mg vials. The contract has a ceiling value of $5,594.70 and runs through August 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs globally. This specific DO contract is not designated with a set-aside requirement, indicating open competition. The contract award demonstrates Amerisourcebergen's role as a critical pharmaceutical distributor and healthcare solutions provider to the federal government, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/8/23 |